This Is MS Multiple Sclerosis Community: Knowledge & Support

Some Campath data from Pubmed...



The window of therapeutic opportunity in multiple sclerosis Evidence from monoclonal antibody therapy.

J Neurol. 2005 Jul 27;

Coles AJ, Cox A, Le Page E, Jones J, Trip SA, Deans J, Seaman S, Miller DH, Hale G, Waldmann H, Compston DA.
Department of Clinical Neurosciences, Box 165, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK, ajc1020@medschl.cam.ac.uk.

From 1991-2002, we treated 58 patients with ...

I went for my 3 month checkup today. Unfortunately I didn't get a neurological assesment but it would only have confirmed what I know. Since treatment my condition has definitely improved. Prior to treatment I was assesed as EDSS 4.0, in my own judgement I have improved by at least 1 EDSS point since treatment, probably more. Hopefully these improvements will continue.

A sobering note to the proceedings was that one patient on the CAMMS223 ...

Hi all,

I had my quarterly appointment for the study yesterday and things went well, though I only dropped to a 1.0 on the EDSS scale. I was hoping for 0.0, but I guess that might be a tad hopeful. Apparently I’m missing some reflex actions in my left foot, and according to the NP it’s unlikely that I’ll ever get them back. Not a big deal as it’s not noticeable unless I get frustrated, ...

Those with a particular interest in Campath might like to follow this link:

http://www.mssociety.org.uk/applications/discussion/browse_moderated.rm?post_id=55222

Consultant neurologist and researcher Dr Alasdair Coles will be answering your questions online, April 6th-13th.

A member of the MS Society Cambridge Centre for Myelin Repair team, Alasdair is a neurologist working on experimental treatments in MS.

Currently Alasdair's main project is coordinating the trial of beta interferon and Campath-1H. Alasdair is also involved in studying the behaviour of immune cells ...

I have been given a chance to participate in the camms224 trial. After carefully weighing up the potential risks and rewards I have decided to go for it. Campath is certainly at the extreme end of MS treatments with some pretty scary potential side effects, but the chance to potentially stop MS in its tracks is far too good to pass up whatever the risks.

I have to have a series of blood tests next ...

Hi all,

Just a quick word on the Campath trials. The one year report was sent out to either he FDA or ILEX pharmasudicals (I’m not sure who it was going to) but the NP who wrote it showed it to me when I was in for my quarterly appointment. The report was for the folk’s who are on the “2nd study”…. the people who were on the various CRABs drugs but weren’t having any ...

Dear all,

I have not heard much about Campath in the last months. News about Campath looked very promising only one year ago. Anybody knows anything about current research and trials ?

Thanks

Ric

Hi

I've been treated with this drug. I've posted my experiences (and those of other patients) on my web site http://www.btinternet.com/~campath/.

If there's anyone out there who's also had it, or is considering taking it, I'd love to make contact.


Rgds

David